불안 관리 디바이스 시장 예측 : 제품, 치료법, 유통 채널, 기술, 용도, 최종사용자 및 지역별 분석(-2034년)

According to Stratistics MRC, the Global Anxiety Management Devices Market is accounted for $3.09 billion in 2026 and is expected to reach $5.63 billion by 2034 growing at a CAGR of 7.7% during the forecast period. Anxiety management devices are specialized medical or wellness technologies designed to monitor, alleviate, and regulate symptoms associated with Anxiety Disorders. These devices utilize approaches such as neurostimulation, biofeedback, heart rate variability tracking, and guided relaxation to influence physiological and psychological responses to stress. Common formats include wearable devices, handheld stimulators, and mobile-connected systems that provide real-time feedback and personalized interventions. Widely used in clinical and home settings, they offer non-invasive, drug-free alternatives or complements to traditional therapies, improving patient outcomes, adherence, and overall mental well-being.

Market Dynamics:

Driver:

Rising prevalence of Anxiety Disorders

The increasing global burden of Anxiety Disorders is a primary driver of the anxiety management devices market. Factors such as urbanization, high work pressure, social isolation, and digital fatigue are contributing to a surge in anxiety-related conditions. This growing patient pool is driving demand for accessible, non-invasive, and continuous treatment solutions. Additionally, early diagnosis trends and rising mental health awareness are encouraging individuals to adopt device-based therapies, thereby accelerating market growth across both clinical and homecare environments.

Restraint:

High cost of advanced devices

The high cost associated with technologically advanced anxiety management devices remains a significant barrier to widespread adoption. Devices incorporating neurostimulation, AI-based analytics, and real-time monitoring systems often involve substantial manufacturing and development expenses, making them less affordable, particularly in emerging economies. Limited insurance reimbursement policies further exacerbate the financial burden on patients. As a result, cost sensitivity restricts market penetration, especially among lower-income populations, thereby slowing the overall growth.

Opportunity:

Technological advancements

Rapid technological advancements present substantial growth opportunities in the market. Innovations in wearable technology, artificial intelligence, and biofeedback systems are enhancing device accuracy, usability, and personalization. Integration with mobile applications and cloud-based platforms enables real-time monitoring and data-driven insights, improving treatment outcomes. Furthermore, the development of compact and cost-effective devices is expanding accessibility. These advancements are fostering increased adoption among consumers, positioning technology as a key enabler of future market expansion.

Threat:

Low awareness in developing regions

Low awareness regarding mental health conditions and available treatment technologies poses a significant threat to market growth in developing regions. In many areas, mental health issues remain stigmatized, leading to underdiagnosis and limited treatment-seeking behavior. Additionally, lack of education about anxiety management devices and their benefits restricts adoption. Insufficient healthcare infrastructure and limited access to trained professionals further compound the challenge. These factors collectively hinder market penetration and slow the adoption.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market, significantly increasing the prevalence of stress, anxiety, and related mental health disorders. Social isolation, economic uncertainty, and health concerns led to a surge in demand for remote and non-invasive treatment solutions. This accelerated the adoption of wearable and home-based anxiety management devices. Additionally, the expansion of telehealth services during the pandemic supported device integration and monitoring. However, supply chain disruptions and economic constraints temporarily affected production and accessibility.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period, due to availability of advanced healthcare infrastructure and skilled professionals. Hospitals serve as primary centers for diagnosis, treatment, and monitoring of anxiety-related conditions, ensuring higher adoption of clinically validated devices. The integration of anxiety management technologies with other therapeutic interventions enhances patient outcomes. Moreover, increased patient inflow, access to reimbursement frameworks, and the presence of multidisciplinary care teams further strengthen the dominance of hospitals in the market.

The neurofeedback segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurofeedback segment is predicted to witness the highest growth rate, due to effectiveness in training brain activity and improving emotional regulation. This non-invasive technique provides real time feedback on brainwave patterns, enabling patients to self-regulate anxiety responses. Growing preference for personalized and drug-free therapies is boosting its adoption. Additionally, technological improvements and increasing clinical validation are enhancing its credibility among healthcare providers. The rising demand for cognitive performance enhancement further supports the rapid growth of this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high awareness of mental health issues, and strong adoption of innovative technologies. The region benefits from significant investments in research and development, along with the presence of key market players. Favorable reimbursement policies and widespread availability of anxiety management devices further drive market growth. Additionally, the rising prevalence of anxiety disorders and increasing acceptance of non-invasive treatments contribute to regional dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing awareness of mental health and rising disposable incomes. Rapid urbanization and changing lifestyles are contributing to higher stress and anxiety levels, driving demand for effective management solutions. Government initiatives promoting mental health and digital healthcare adoption further support market expansion. Additionally, the growing penetration of wearable technologies and mobile health platforms is accelerating the adoption of anxiety management devices across the region.

Key players in the market

Some of the key players in Anxiety Management Devices Market include Fisher Wallace Laboratories, Electromedical Products International, Mind Alive Inc., BrainMaster Technologies Inc., Thought Technology Ltd., Mind Media B.V., Neurobit Systems, HeartMath LLC, NeuroSky Inc., InteraXon Inc., Emotiv Inc., Neuroelectrics, BrainsWay Ltd., Neuronetics Inc. and Medtronic plc.

Key Developments:

In March 2026, Medtronic plc expanded its multiyear alliance with GE HealthCare to accelerate next-generation innovation, integrate advanced patient monitoring technologies, and enhance clinical solutions, enabling more efficient workflows, improved patient outcomes, and broader access to connected, data-driven healthcare systems globally.

In February 2026, Medtronic announced its intent to acquire CathWorks for up to $585 million, strengthening its cardiovascular portfolio. The deal builds on their 2022 partnership and integrates AI-based FFRangio technology to enhance coronary disease diagnosis and treatment, pending regulatory approval.

Products Covered:

• Wearable Devices
• Neurostimulation Devices
• Biofeedback & Neurofeedback Devices
• Virtual Reality (VR) Devices
• Audiovisual Relaxation Devices
• Mobile Connected Devices

Treatment Modalities Covered:

• Cognitive Behavioral Therapy (CBT) Devices
• Meditation & Relaxation Devices
• Biofeedback Therapy Devices
• Neurostimulation Therapy Devices

Distribution Channels Covered:

• Online Sales
• Offline Sales

Technologies Covered:

• Biofeedback
• Neurofeedback
• Electrotherapy
• VR-Based Therapy
• Sensor-Based Monitoring

Applications Covered:

• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Obsessive Compulsive Disorder (OCD)
• Specific Phobias
• Other Applications

End Users Covered:

• Hospitals
• Specialty Clinics
• Home Care Settings
• Rehabilitation Centers
• Educational Institutions

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Anxiety Management Devices Market, By Product

• 5.1 Wearable Devices
• 5.2 Neurostimulation Devices
• 5.3 Biofeedback & Neurofeedback Devices
• 5.4 Virtual Reality (VR) Devices
• 5.5 Audiovisual Relaxation Devices
• 5.6 Mobile Connected Devices

6 Global Anxiety Management Devices Market, By Treatment Modality

• 6.1 Cognitive Behavioral Therapy (CBT) Devices
• 6.2 Meditation & Relaxation Devices
• 6.3 Biofeedback Therapy Devices
• 6.4 Neurostimulation Therapy Devices

7 Global Anxiety Management Devices Market, By Distribution Channel

• 7.1 Online Sales
• 7.2 Offline Sales

8 Global Anxiety Management Devices Market, By Technology

• 8.1 Biofeedback
• 8.2 Neurofeedback
• 8.3 Electrotherapy
• 8.4 VR-Based Therapy
• 8.5 Sensor-Based Monitoring

9 Global Anxiety Management Devices Market, By Application

• 9.1 Generalized Anxiety Disorder
• 9.2 Panic Disorder
• 9.3 Social Anxiety Disorder
• 9.4 Post-Traumatic Stress Disorder (PTSD)
• 9.5 Obsessive Compulsive Disorder (OCD)
• 9.6 Specific Phobias
• 9.7 Other Applications

10 Global Anxiety Management Devices Market, By End User

• 10.1 Hospitals
• 10.2 Specialty Clinics
• 10.3 Home Care Settings
• 10.4 Rehabilitation Centers
• 10.5 Educational Institutions

11 Global Anxiety Management Devices Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Fisher Wallace Laboratories
• 14.2 Electromedical Products International
• 14.3 Mind Alive Inc.
• 14.4 BrainMaster Technologies Inc.
• 14.5 Thought Technology Ltd.
• 14.6 Mind Media B.V.
• 14.7 Neurobit Systems
• 14.8 HeartMath LLC
• 14.9 NeuroSky Inc.
• 14.10 InteraXon Inc.
• 14.11 Emotiv Inc.
• 14.12 Neuroelectrics
• 14.13 BrainsWay Ltd.
• 14.14 Neuronetics Inc.
• 14.15 Medtronic plc